[ad_1]
Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan
[ad_2]
Source link
Weight-loss drugs may be coming to Medicare, Medicaid under experimental program
Related Posts
RH CEO: ‘Significant inflation’ to hit this year, and gather speed in 2026 and beyond
[ad_1] Inflation will rear its head in earnest this year and “accelerate into 2026 and beyond,” RH CEO Gary Friedman…
Lululemon says it has gotten ‘too predictable,’ as tariffs, outlook sink its stock
[ad_1] Shares of Lululemon Athletica Inc. tumbled after hours on Thursday after the yoga-wear maker cut its full-year outlook, citing…
As Dalio gets out of Bridgewater, Bridgewater gets out of China
[ad_1] Ray Dalio’s departure coincides with the liquidation of Bridgewater’s Chinese exposure – just as the market is rebounding. [ad_2]…